Gene · 4928
Papers2,783
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,783
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interdependence between Nuclear Pore Gatekeepers and Genome Caretakers: Cues from Genome Instability Syndromes. | Int J Mol Sci | 2024 | 39273335 | PubTator, text mining | PubMed |
| Targeted gene sequencing and transcriptome sequencing reveal characteristics of NUP98 rearrangement in pediatric acute myeloid leukemia. | Eur J Med Res | 2024 | 39223643 | PubTator, text mining | PubMed |
| Detection of TurboID fusion proteins by fluorescent streptavidin outcompetes antibody signals and visualises targets not accessible to antibodies. | Elife | 2024 | 39206942 | PubTator, text mining | PubMed |
| Genomic landscape of early-stage prostate adenocarcinoma in Mexican patients: an exploratory study. | Discov Oncol | 2024 | 39196408 | PubTator, text mining | PubMed |
| NUP98::NSD1 and FLT3/ITD co-expression is an independent predictor of poor prognosis in pediatric AML patients. | BMC Pediatr | 2024 | 39182032 | PubTator, text mining | PubMed |
| Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community. | Leukemia | 2024 | 39179671 | PubTator, text mining | PubMed |
| Specific multivalent molecules boost CRISPR-mediated transcriptional activation. | Nat Commun | 2024 | 39174527 | PubTator, text mining | PubMed |
| NUP98 is rearranged in 5.0% of adult East Asian patients with AML. | Blood Adv | 2024 | 39158088 | PubTator, text mining | PubMed |
| The DNA-PAINT palette: a comprehensive performance analysis of fluorescent dyes. | Nat Methods | 2024 | 39112798 | PubTator, text mining | PubMed |
| POU6F2, a novel fusion partner of NUP98 in acute myeloid leukaemia: A case report. | Br J Haematol | 2024 | 39073102 | PubTator, text mining | PubMed |
| "Off-pore" nucleoporins relocalize heterochromatic breaks through phase separation. | bioRxiv | 2024 | 39071440 | PubTator, text mining | PubMed |
| Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1. | BMC Pediatr | 2024 | 39068406 | PubTator, text mining | PubMed |
| HOXA9 Regulome and Pharmacological Interventions in Leukemia. | Adv Exp Med Biol | 2024 | 39017854 | PubTator, text mining | PubMed |
| Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia. | Am J Hematol | 2024 | 39016111 | PubTator, text mining | PubMed |
| Real-World Clinical Utility of Targeted RNA Sequencing in Leukemia Diagnosis and Management. | Cancers (Basel) | 2024 | 39001529 | PubTator, text mining | PubMed |
| Pre-ribosomal particles from nucleoli to cytoplasm. | Nucleus | 2024 | 38940456 | PubTator, text mining | PubMed |
| NUP98-BPTF promotes oncogenic transformation through PIM1 upregulation. | Cancer Med | 2024 | 38940430 | PubTator, text mining | PubMed |
| CircNUP98 promotes the malignant behavior of glioma cells through the miR-520f-3p/ELK4 axis. | Int J Dev Neurosci | 2024 | 38923578 | PubTator, text mining | PubMed |
| Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics. | Sci Rep | 2024 | 38902252 | PubTator, text mining | PubMed |
| Combination of menin and kinase inhibitors as an effective treatment for leukemia with NUP98 translocations. | Leukemia | 2024 | 38890447 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4928/papers?page=9